Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570791 · ClinicalTrials.gov registry record
Effect of Central Corneal Thickness On IOP Using Various Tonometers
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 166
- Enrollment target
NCT00570791: Completed study, sponsored by University of Nebraska.
NCT00570791 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00570791 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the effects of ocular physical properties on intraocular pressure (IOP) measurements in eyes with healthy corneas using the following instruments to measure IOP: Goldmann applanation tonometer, pneumotonometer, ocular blood flow pneumotonometer, Tono-Pen, Pascal Dynamic Contour Tonometer and the Schiotz Tonometer. Ocular physical properties to be evaluated are:varying (CCT), corneal curvature (CC), axial length, anterior chamber depth and scleral rigidity. The secondary purpose of this is to determine if there is a correlation between CCT and other ocular properties, and which instruments that measure these other ocular properties are most affected by CCT.
Primary Outcome
Measured pressure in participants' eyes with six different tonometers
Interventions
- DEVICE Tonometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2005-06-29 |
| Est. Completion | 2011-11-01 |
What the finished NCT00570791 record still lists
NCT00570791 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Tonometer is the first listed.
NCT00570791 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00570791 about?
NCT00570791 is a clinical study titled "Effect of Central Corneal Thickness On IOP Using Various Tonometers". The primary purpose of this study is to evaluate the effects of ocular physical properties on intraocular pressure (IOP) measurements in eyes with healthy corneas using the following instruments to measure IOP: Goldmann applanation tonometer, pneumotonometer, ocular blood flow pneumotonometer, Tono-...
What is the current status of trial NCT00570791?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2005-06-29. Estimated completion is 2011-11-01.
What interventions are being tested in trial NCT00570791?
The interventions under investigation include: Tonometer (DEVICE).
Who is sponsoring clinical trial NCT00570791?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI